Key points are not available for this paper at this time.
This study provides Class III evidence that serum GDF-15 accurately distinguishes patients with mitochondrial diseases from those without them.
Davis et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: